Literature DB >> 19759099

18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.

Eric C Ford1, Joseph Herman, Ellen Yorke, Richard L Wahl.   

Abstract

Advances in technology have allowed extremely precise control of radiation dose delivery and localization within a patient. The ability to confidently delineate target tumor boundaries, however, has lagged behind. (18)F-FDG PET/CT, with its ability to distinguish metabolically active disease from normal tissue, may provide a partial solution to this problem. Here we review the current applications of (18)F-FDG PET/CT in a variety of disease sites, including non-small cell lung cancer, head and neck cancer, and pancreatic adenocarcinoma. This review focuses on the use of (18)F-FDG PET/CT to aid in planning radiotherapy and the associated benefits and challenges. We also briefly consider novel radiopharmaceuticals that are beginning to be used in the context of radiotherapy planning.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19759099      PMCID： PMC2899678          DOI： 10.2967/jnumed.108.055780

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  119 in total

1.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.

Authors:  A Eisbruch; R K Ten Haken; H M Kim; L H Marsh; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-10-01       Impact factor: 7.038

2.  Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors.

Authors:  V S Khoo; M Oldham; E J Adams; J L Bedford; S Webb; M Brada
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

3.  Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects.

Authors:  M T Munley; L B Marks; C Scarfone; G S Sibley; E F Patz; T G Turkington; R J Jaszczak; D R Gilland; M S Anscher; R E Coleman
Journal:  Lung Cancer       Date:  1999-02       Impact factor: 5.705

4.  Cone-beam computed tomography with a flat-panel imager: initial performance characterization.

Authors:  D A Jaffray; J H Siewerdsen
Journal:  Med Phys       Date:  2000-06       Impact factor: 4.071

5.  18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis.

Authors:  U Nestle; K Walter; S Schmidt; N Licht; C Nieder; B Motaref; D Hellwig; M Niewald; D Ukena; C M Kirsch; G W Sybrecht; K Schnabel
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-06-01       Impact factor: 7.038

6.  Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma.

Authors:  F Crippa; M Leutner; F Belli; F Gallino; M Greco; S Pilotti; N Cascinelli; E Bombardieri
Journal:  J Nucl Med       Date:  2000-09       Impact factor: 10.057

7.  FDG PET measurement of the proliferative potential of non-small cell lung cancer.

Authors:  K Higashi; Y Ueda; M Yagishita; Y Arisaka; A Sakurai; M Oguchi; H Seki; Y Nambu; H Tonami; I Yamamoto
Journal:  J Nucl Med       Date:  2000-01       Impact factor: 10.057

8.  Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

Authors:  B A Dwamena; S S Sonnad; J O Angobaldo; R L Wahl
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

9.  A combined PET/CT scanner for clinical oncology.

Authors:  T Beyer; D W Townsend; T Brun; P E Kinahan; M Charron; R Roddy; J Jerin; J Young; L Byars; R Nutt
Journal:  J Nucl Med       Date:  2000-08       Impact factor: 10.057

10.  The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.

Authors:  L J Vanuytsel; J F Vansteenkiste; S G Stroobants; P R De Leyn; W De Wever; E K Verbeken; G G Gatti; D P Huyskens; G J Kutcher
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280
View more
  43 in total

1.  Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe.

Authors:  Wael R Abd-Elgaliel; Zobeida Cruz-Monserrate; Craig D Logsdon; Ching-Hsuan Tung
Journal:  Mol Biosyst       Date:  2011-09-20

2.  Recommendations for the use of PET and PET-CT for radiotherapy planning in research projects.

Authors:  E J Somer; L C Pike; P K Marsden
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

3.  Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer.

Authors:  James D Murphy; Trang H La; Karen Chu; Andrew Quon; Nancy J Fischbein; Peter G Maxim; Edward E Graves; Billy W Loo; Quynh-Thu Le
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

Review 4.  Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments.

Authors:  P M Price; M M Green
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

Review 5.  Positron emission tomography for benign and malignant disease.

Authors:  Anthony Visioni; Julian Kim
Journal:  Surg Clin North Am       Date:  2011-02       Impact factor: 2.741

Review 6.  Multiplexed imaging in cancer diagnosis: applications and future advances.

Authors:  Hisataka Kobayashi; Michelle R Longmire; Mikako Ogawa; Peter L Choyke; Satomi Kawamoto
Journal:  Lancet Oncol       Date:  2010-03-24       Impact factor: 41.316

7.  Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy.

Authors:  Avani S Dholakia; Muhammad Chaudhry; Jeffrey P Leal; Daniel T Chang; Siva P Raman; Amy Hacker-Prietz; Zheng Su; Jonathan Pai; Katharine E Oteiza; Mary E Griffith; Richard L Wahl; Erik Tryggestad; Timothy Pawlik; Daniel A Laheru; Christopher L Wolfgang; Albert C Koong; Joseph M Herman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-18       Impact factor: 7.038

8.  IMRT and IGRT in head and neck cancer: Have we delivered what we promised?

Authors:  Gupta Tejpal; Agarwal Jaiprakash; Bannerjee Susovan; Sarbani Ghosh-Laskar; Vedang Murthy; Ashwini Budrukkar
Journal:  Indian J Surg Oncol       Date:  2010-11-21

9.  New perspectives in radiation oncology: Young radiation oncologist point of view and challenges.

Authors:  Jose Luis Lopez Guerra; Nicolas Isa; Michelle M Kim; Celine Bourgier; Hugo Marsiglia
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-09

10.  Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation.

Authors:  Sonali Rudra; Amol K Narang; Timothy M Pawlik; Hao Wang; Elizabeth M Jaffee; Lei Zheng; Dung T Le; David Cosgrove; Ralph H Hruban; Elliot K Fishman; Richard Tuli; Daniel A Laheru; Christopher L Wolfgang; Luis A Diaz; Joseph M Herman
Journal:  Pract Radiat Oncol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.